Equels Thomas K (CIK 1450324) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-16). Recent activity: Buy AIM (25,000 shares), Buy AIM (107 shares), Buy AIM (103 shares), Buy AIM (2.0M shares), Buy AIM (41,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-16 | AIM ImmunoTech Inc. (AIM) | CEO & President | Buy | 25,000 | $0 |
| 2025-06-16 | AIM ImmunoTech Inc. (AIM) | CEO & President | Buy | 107 | $824 |
| 2025-06-13 | AIM ImmunoTech Inc. (AIM) | CEO & President | Buy | 103 | $896 |
| 2025-04-23 | AIM ImmunoTech Inc. (AIM) | CEO & President | Buy | 2.0M | $0 |
| 2025-04-07 | AIM ImmunoTech Inc. (AIM) | CEO & President | Buy | 41,000 | $0 |
| 2025-03-06 | AIM ImmunoTech Inc. (AIM) | CEO & President | Buy | 50,000 | $0 |
| 2025-03-05 | AIM ImmunoTech Inc. (AIM) | CEO & President | Buy | 44,000 | $0 |
| 2025-03-04 | AIM ImmunoTech Inc. (AIM) | CEO & President | Buy | 83,334 | $0 |
| 2025-01-21 | AIM ImmunoTech Inc. (AIM) | CEO & President | Buy | 20,000 | $0 |
Source: SEC Form 4 filings · as of 2026-03-16